Interested in joining our research group?
We have currently several Honours, Masters and PhD positions available in the our research group. For more information, email markus.hofer@sydney.edu.au
Current project AREAS
TARGETING THE BRAIN VASCULATURE AS A TREATMENT FOR CEREBRAL TYPE I INTERFERONOPATHIES
Abnormal blood vessels are feature of cerebral type I interferonopathies. Discover how the endothelial cells that line the brain’s blood vessels contribute to disease in patients with cerebral type I interferonopathies.
THE PATHOGENIC AND PROTECTIVE EFFECTS OF MICROGLIA IN CEREBRAL CYTOKINOPATHIES
Microglia are the primary immune cells of the brain and have the potential to both protect and contribute to neurological disease. Explore the molecular mechanisms that microglia use to mediate their biological effects in cerebral cytokinopathies.
HOW DIFFERENT CELL TYPES OF THE BRAIN CONTRIBUTE TO CEREBRAL CYTOKINOPATHIES
The brain consists of a large number of different cell types, including neurons, astrocytes, oligodendrocytes, microglia and endothelial cells. Discover how these different cell types mediate the pathogenesis of cerebral cytokinopathies using transgenic mouse models.